U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Nucleic Acid
Created
by admin
on Wed Apr 02 07:33:07 GMT 2025
Edited
by admin
on Wed Apr 02 07:33:07 GMT 2025
Nucleic Acid Type MRNA
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
WGT2OMP6LX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BNT111 COMPONENT GINDAMERAN
Preferred Name English
Gindameran
USAN   INN  
Official Name English
FixVac component Gindameran
Brand Name English
GINDAMERAN [USAN]
Common Name English
RNA (recombinant [1,2-[m7Gm-p-[P(R)]-sp-p-G]]-capped human cancer testis antigen NY-ESO-1-specifying poly(A)-tailed messenger RBL001.3), inner salt -
Common Name English
RNA (RECOMBINANT (1,2-(M7GM-P-(P(R))-SP-P-G))-CAPPED HUMAN CANCER TESTIS ANTIGEN NY-ESO-1-SPECIFYING POLY(A)-TAILED MESSENGER RBL001.3), INNER SALT
Common Name English
RBL001.3
Code English
BNT-111 COMPONENT NY-ESO-1 FUSION PROTEIN EXPRESSING RNA
Common Name English
RBL-001.3
Code English
gindameran [INN]
Common Name English
FIXVAC RNA MELANOMA VACCINE COMPONENT EXPRESSING THE NY-ESO-1 FUSION PROTEIN T-CELL ANTIGEN
Common Name English
MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING CODON-OPTIMISED NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA ANTIGEN-1 (NY-ESO-1 CANCER/TESTIS ANTIGEN 1, CTAG1A) EXPRESSED AS A FUSION PROTEIN COMPRISING A SECRETORY SIGNAL PEPTIDE, NY-ESO-1, P2P16 TETANUS TOXOID
Common Name English
Code System Code Type Description
INN
11477
Created by admin on Wed Apr 02 07:33:07 GMT 2025 , Edited by admin on Wed Apr 02 07:33:07 GMT 2025
PRIMARY
USAN
KL-141
Created by admin on Wed Apr 02 07:33:07 GMT 2025 , Edited by admin on Wed Apr 02 07:33:07 GMT 2025
PRIMARY
SMS_ID
300000024533
Created by admin on Wed Apr 02 07:33:07 GMT 2025 , Edited by admin on Wed Apr 02 07:33:07 GMT 2025
PRIMARY
NCI_THESAURUS
C175791
Created by admin on Wed Apr 02 07:33:07 GMT 2025 , Edited by admin on Wed Apr 02 07:33:07 GMT 2025
PRIMARY
FDA UNII
WGT2OMP6LX
Created by admin on Wed Apr 02 07:33:07 GMT 2025 , Edited by admin on Wed Apr 02 07:33:07 GMT 2025
PRIMARY
EMA SUBSTANCE ID
SUB216754
Created by admin on Wed Apr 02 07:33:07 GMT 2025 , Edited by admin on Wed Apr 02 07:33:07 GMT 2025
PRIMARY
CAS
2348560-89-2
Created by admin on Wed Apr 02 07:33:07 GMT 2025 , Edited by admin on Wed Apr 02 07:33:07 GMT 2025
PRIMARY
Sugar Site Range Site Count
D-Ribose (RNA) 1_1-1_1565 1565 / 1565
Linkage Site Range Site Count
Phosphate 1_2-1_1565 1564 / 1564
Related Record Type Details
TARGET->VACCINE ANTIGEN
Related Record Type Details
ACTIVE MOIETY
Immunomodulator, antineoplastic

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
NUCLEOTIDE SUBSTITUTION [1_1] 5'-TERMINUS UNSPECIFIED SUBSTANCE
fd4a4c35
(not in database)